Impact of austerity on European pharmaceutical policy and pricing

Staying competitive in a challenging environment

Deloitte UK Centre for Health Solutions report addresses current challenges faced by the pharmaceutical industry due to on-going austerity in Europe

The current financial climate has placed significant pressure on public spending and while the majority of governments’ acknowledge healthcare provision to be strategically important, their willingness and ability to pay is subject to increasing pressures.

Discover more about this report. 

Did you find this useful?